Sorafenib Tablet is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer(hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma. Yes! I am interested